CYTOKINETICS, INCORPORATED Operating Lease Liability
CYTOKINETICS, INCORPORATED (CYTK) had Operating Lease Liability of $127.08 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-26
- 2025-12-31: Operating Lease, Liability $127.08M.
- 2024-12-31: Operating Lease, Liability $131.56M.
- 2023-12-31: Operating Lease, Liability $138.32M.
- 2022-12-31: Operating Lease, Liability $139.72M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $127.08M 10-K · filed 2026-02-26 |
| 2024-12-31 | $131.56M 10-K · filed 2025-02-27 |
| 2023-12-31 | $138.32M 10-K · filed 2024-02-28 |
| 2022-12-31 | $139.72M 10-K · filed 2023-03-01 |
| 2022-09-30 | $130.46M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $127.03M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $126.51M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $127.09M 10-K · filed 2022-02-25 |
| 2021-09-30 | $119.90M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $107.90M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $90.93M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $3.23M 10-K · filed 2021-02-26 |
| 2020-09-30 | $4.46M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $5.67M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $6.80M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $6.81M 10-K · filed 2020-03-04 |
| 2019-09-30 | $7.83M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $8.83M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $9.77M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $10.70M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |